Shirley Henderson
Overview
Explore the profile of Shirley Henderson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
765
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sosinsky A, Ambrose J, Cross W, Turnbull C, Henderson S, Jones L, et al.
Nat Med
. 2024 Jan;
30(1):279-289.
PMID: 38200255
The Cancer Programme of the 100,000 Genomes Project was an initiative to provide whole-genome sequencing (WGS) for patients with cancer, evaluating opportunities for precision cancer care within the UK National...
2.
Cutts A, Vavoulis D, Petrou M, Smith F, Clark B, Henderson S, et al.
Blood
. 2019 Aug;
134(14):1190-1193.
PMID: 31444163
No abstract available.
3.
Turnbull C, Scott R, Thomas E, Jones L, Murugaesu N, Pretty F, et al.
BMJ
. 2018 Apr;
361:k1687.
PMID: 29691228
No abstract available.
4.
Robbe P, Popitsch N, Knight S, Antoniou P, Becq J, He M, et al.
Genet Med
. 2018 Feb;
20(10):1196-1205.
PMID: 29388947
Purpose: Fresh-frozen (FF) tissue is the optimal source of DNA for whole-genome sequencing (WGS) of cancer patients. However, it is not always available, limiting the widespread application of WGS in...
5.
Hamblin A, Wordsworth S, Fermont J, Page S, Kaur K, Camps C, et al.
PLoS Med
. 2017 Feb;
14(2):e1002230.
PMID: 28196074
Background: Single gene tests to predict whether cancers respond to specific targeted therapies are performed increasingly often. Advances in sequencing technology, collectively referred to as next generation sequencing (NGS), mean...
6.
Deans Z, Costa J, Cree I, Dequeker E, Edsjo A, Henderson S, et al.
Virchows Arch
. 2016 Sep;
470(1):5-20.
PMID: 27678269
The clinical demand for mutation detection within multiple genes from a single tumour sample requires molecular diagnostic laboratories to develop rapid, high-throughput, highly sensitive, accurate and parallel testing within tight...
7.
Kaisaki P, Cutts A, Popitsch N, Camps C, Pentony M, Wilson G, et al.
PLoS One
. 2016 Sep;
11(9):e0162809.
PMID: 27626278
Use of circulating tumour DNA (ctDNA) as a liquid biopsy has been proposed for potential identification and monitoring of solid tumours. We investigate a next-generation sequencing approach for mutation detection...
8.
Roy N, Wilson E, Henderson S, Wray K, Babbs C, Okoli S, et al.
Br J Haematol
. 2016 Jul;
175(2):318-330.
PMID: 27432187
Accurate diagnosis of rare inherited anaemias is challenging, requiring a series of complex and expensive laboratory tests. Targeted next-generation-sequencing (NGS) has been used to investigate these disorders, but the selection...
9.
Aleksic T, Browning L, Woodward M, Phillips R, Page S, Henderson S, et al.
Front Oncol
. 2016 May;
6:98.
PMID: 27200287
Chordomas are rare primary malignant bone tumors arising from embryonal notochord remnants of the axial skeleton. Chordomas commonly recur following surgery and radiotherapy, and there is no effective systemic therapy....
10.
Traeger-Synodinos J, Harteveld C, Old J, Petrou M, Galanello R, Giordano P, et al.
Eur J Hum Genet
. 2015 Mar;
23(4):560.
PMID: 25762031
No abstract available.